共 50 条
- [2] Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis Dermatology and Therapy, 2023, 13 : 2589 - 2603
- [6] Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis Dermatology and Therapy, 2023, 13 : 2605 - 2607